Supha Pharmachem Share Price
0.26+0.01 (+4.00%)
-82.78% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
ADANIENT-ANSE
CPPLUS-ANSE
AEGISLOG-ANSE
PREMIERENE-ANSE
REDINGTON-ANSE
HONASA-ANSE
LLOYDSENT-ANSE
CELLO-ANSE
JSLL-ANSE
SREEL-TNSE
SUPHA-ZNSE
Supha Pharmachem Share Price
0.26+0.01 (+4.00%)
-82.78% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | - | - | 0% |
| - | - | - | 0% |
| - | -34% | -83% | -83% |
| 5% | 5% | 5% | 5% |
Peer Comparison
Symbol
ADANIENT-A
CPPLUS-A
AEGISLOG-A
PREMIERENE-A
REDINGTON-A
HONASA-A
LLOYDSENT-A
CELLO-A
JSLL-A
SREEL-T
SUPHA-Z
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 2,633.1 | ₹351291 Cr | 47.19 | -8.91 | 105.06 | ₹9339 Cr |
| 4,186.05 | ₹48720 Cr | 102.08 | 12.07 | 43.69 | ₹368 Cr |
| 1,385.55 | ₹48542 Cr | 38.79 | 13.8 | 41.65 | ₹898 Cr |
| 895 | ₹40220 Cr | 24.16 | 10.2 | 45.28 | ₹1510 Cr |
| 379.6 | ₹30329 Cr | 17.83 | 6.22 | 24.36 | ₹1490 Cr |
| 467 | ₹15237 Cr | 61.22 | 2.77 | 8.99 | ₹200 Cr |
| 73.7 | ₹11391 Cr | 101.44 | 0.38 | 0.91 | ₹283 Cr |
| 365.3 | ₹8476 Cr | 27.09 | 3.32 | 17.46 | ₹332 Cr |
| 387.65 | ₹4740 Cr | 20.04 | 5.31 | 23.32 | ₹222 Cr |
| 272.65 | ₹645 Cr | 19.65 | 3.02 | 14.74 | ₹29 Cr |
| 0.26 | ₹22 Cr | 10.35 | 0.1 | 0.02 | ₹2 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
| Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|
| ₹111 Cr | ₹113 Cr | ₹264 Cr |
| ₹3 Cr | ₹3 Cr | ₹66 L |
| ₹114 Cr | ₹117 Cr | ₹265 Cr |
| ₹104 Cr | ₹111 Cr | ₹265 Cr |
| ₹11 Cr | ₹5 Cr | ₹20 L |
| ₹19 L | -₹37 L | ₹2 Cr |
| ₹10 Cr | ₹6 Cr | -₹1 Cr |
| ₹9 Cr | ₹5 Cr | -₹2 Cr |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Deferred Tax Assets / Liabilities
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2025 |
|---|
| — |
| ₹40 Cr |
| ₹4 Cr |
| ₹4 Cr |
| ₹44 Cr |
| -₹4 L |
| -₹4 L |
| — |
| ₹501 Cr |
| ₹32 Cr |
| ₹1141 Cr |
| ₹2 Cr |
| ₹1676 Cr |
| ₹1720 Cr |
| ₹1141 Cr |
| — |
| ₹22 L |
| ₹22 L |
| ₹83,000 |
| ₹83,000 |
| — |
| ₹269 Cr |
| ₹772 Cr |
| ₹1 Cr |
| ₹3 Cr |
| ₹675 Cr |
| ₹1720 Cr |
| ₹44 Cr |
| ₹1720 Cr |
| ₹1 |
| ₹1 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Closing Cash & Cash Equivalent
| Mar 2025 |
|---|
| ₹4 Cr |
| ₹5 Cr |
| -₹1144 Cr |
| -₹1135 Cr |
| -₹1135 Cr |
| ₹13 L |
| ₹1136 Cr |
| ₹1 Cr |
| ₹1 Cr |
Fundamental Ratios
Consolidated
Standalone
No results found
Supha Pharmachem Share Price
0.26+0.01 (+4.00%)
-82.78% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 2
Bearish signals: 3 out of 9 oscillators
RSI
45.50Neutral
STOCH %K
66.67Neutral
MACD Level(12,26)
-0.01Sell
Ultimate Oscillator
52.34Buy
Aroon Oscillator
-92.00Sell
BOP
0.50Buy
CCI
-96.69Neutral
Williams %R
-33.33Neutral
Momentum
-0.01Sell
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 0
Bearish signals: 4 out of 9 moving averages
EMA 9
0.26Neutral
SMA 9
0.26Neutral
EMA 21
0.26Neutral
SMA 21
0.26Neutral
EMA 50
0.28Sell
SMA 50
0.29Sell
EMA 200
0.54Sell
SMA 200
0.53Sell
WMA 20
0.26Neutral
Pivot
Pivot
Classic
Resistance 5
0.33
Resistance 4
0.31
Resistance 3
0.29
Resistance 2
0.27
Resistance 1
0.26
Pivot
0.25
Support 1
0.24
Support 2
0.23
Support 3
0.21
Support 4
0.19
Support 5
0.17
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Supha Pharmachem Share Price
0.26+0.01 (+4.00%)
-82.78% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|
| 1.13% | 1.13% | 1.13% | 1.11% | 1.11% | 1.11% |
| 1.70% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 97.17% | 98.87% | 98.87% | 98.89% | 98.89% | 98.89% |
Bulk & block deals
Name
Prakash Anand Gupta
Rg Traders
Rg Traders
Aakashhiteshbhaizinzuvadia
L7 Hitech Private Limited
Share India Securities Limited
Jasmitsinghchandhok
Ishaan Tradefin Llp
Share India Securities Limited
Ishaan Tradefin Llp
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 17 Jun 2026 | Sell | 17.58 L | ₹0.27 | 65.10 L | Bulk | 0.738151 | BSE |
| 07 Apr 2026 | Sell | 15.15 L | ₹0.34 | 44.56 L | Bulk | 0.505169 | BSE |
| 30 Mar 2026 | Purchase | 23.69 L | ₹0.32 | 74.02 L | Bulk | 0.839249 | BSE |
| 30 Mar 2026 | Sell | 18.19 L | ₹0.32 | 56.85 L | Bulk | 0.644565 | BSE |
| 18 Mar 2026 | Sell | 29.79 L | ₹0.39 | 76.38 L | Bulk | 0.865968 | BSE |
| 12 Mar 2026 | Purchase | 44.02 L | ₹0.47 | 93.67 L | Bulk | 1.062016 | BSE |
| 12 Mar 2026 | Purchase | 33.84 L | ₹0.47 | 72 L | Bulk | 0.816336 | BSE |
| 12 Mar 2026 | Purchase | 4.23 L | ₹0.45 | 9.39 L | Bulk | 0.106464 | BSE |
| 12 Mar 2026 | Sell | 41.69 L | ₹0.46 | 90.64 L | Bulk | 1.027677 | BSE |
| 12 Mar 2026 | Sell | 27.32 L | ₹0.46 | 59.39 L | Bulk | 0.673364 | BSE |
Insider trading & SAST
Client name
Mr. Mukesh Naresh
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15 Jun 2022 | Directors Immediate Relative | Acquisition | 0.202778 | 1.62 | 10.01 L | ₹137.06 | 7.30 K | 14 Jun 2022 | Market Purchase | 58,405 | Insider Trading | — | Equity Shares |
Supha Pharmachem Share Price
0.26+0.01 (+4.00%)
-82.78% past 1 Year
Remedium Lifecare Ltd. (formerly known as Roxy Exports Limited) is pharmaceutical company aligned across two business verticals viz. Products and Services. Its Products business comprises manufacture and sale of APIs
Corporate Actions
Date
Type
Details
Company details
Supha Pharmachem Share Price
0.26+0.01 (+4.00%)
-82.78% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
No presentations found
Supha Pharmachem Share Price
0.26+0.01 (+4.00%)
-82.78% past 1 Year
News
Supha Pharmachem informs about board meeting
Equity
SUPHA